JP2011068630A - Composition used for preventing and treating periodontal disease - Google Patents

Composition used for preventing and treating periodontal disease Download PDF

Info

Publication number
JP2011068630A
JP2011068630A JP2009241844A JP2009241844A JP2011068630A JP 2011068630 A JP2011068630 A JP 2011068630A JP 2009241844 A JP2009241844 A JP 2009241844A JP 2009241844 A JP2009241844 A JP 2009241844A JP 2011068630 A JP2011068630 A JP 2011068630A
Authority
JP
Japan
Prior art keywords
periodontal disease
bacteria
biofilm
biofilms
calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009241844A
Other languages
Japanese (ja)
Inventor
Noboru Kamibayashi
登 上林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2009241844A priority Critical patent/JP2011068630A/en
Publication of JP2011068630A publication Critical patent/JP2011068630A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a drug which destructs biofilms formed by periodontal disease-related bacteria, kills periodontal disease bacteria, and controls the formation of the biofilms. <P>SOLUTION: The effective component of the composition for the oral cavity which destructs biofilms, kills periodontal disease bacteria, and controls the formation of biofilms is a highly alkaline solution having a pH of ≥12 obtained by preparing a 0.1-0.2% aqueous solution of calcined shell calcium. <P>COPYRIGHT: (C)2011,JPO&INPIT

Description

本発明は、歯周炎及び口臭抑制効果に優れ、歯周病の予防又は治療、更には口臭の予防又は抑制に有効な口腔用組成物に関する。The present invention relates to a composition for oral cavity that is excellent in periodontitis and halitosis suppression effects and is effective in preventing or treating periodontal disease, and further in preventing or suppressing halitosis.

歯周病は口腔内に「歯周病菌」と総称される細菌が感染し、デンタルプラーク(歯垢)と呼ばれる構造を形成して炎症などを引き起こす疾患である。デンタルプラークの実体は細菌が細胞外に分泌する種々の物質(タンパク質、多糖類など)からなるバイオフィルムであり、この中にある細菌は貧食細胞や抗体などから守られ、また内部で毒素を放出し歯周組織を破壊するなどの挙動を示すことが知られている。歯周病は一種類の細菌が起こすのでは無く、複数種の細菌が複合的に感染して引き起こされるのが特徴であり、主要な菌種としてはActinobacillus actinomycetemcomitans,Porphyromonas gingivalisなどが知られている。またEikenella corrodensも、日和見感染的に増殖する歯周病関連菌として知られている。Periodontal disease is a disease in which bacteria collectively called “periodontal disease bacteria” are infected in the oral cavity, forming a structure called dental plaque (plaque) and causing inflammation. The substance of dental plaque is a biofilm made up of various substances (proteins, polysaccharides, etc.) secreted by bacteria outside the cell, and the bacteria in this are protected from phagocytic cells and antibodies, and also have toxins inside. It is known to exhibit behavior such as release and destruction of periodontal tissue. Periodontal disease is not caused by one type of bacteria but is caused by multiple infections of multiple types of bacteria. Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, etc. are known as the main bacterial species . Eikenella corrodens is also known as a periodontal disease-related bacterium that proliferates in an opportunistic manner.

歯周病の予防には、毎日の歯磨きで口腔内細菌にデンタルプラークの形成を行わせない様にする事が最も重要であるが、実際問題として歯磨き不足による磨き残しにより、毎日、バイオフィルムが形成されてしまう。歯周病の原因となっているバイオフィルムは、主として歯あるいは根の表面につき、歯ぐきはこのバイオフィルムに面しているために腫れなどの症状を起こす。For prevention of periodontal disease, it is most important to prevent oral bacteria from forming dental plaque with daily tooth brushing. Will be formed. The biofilm causing periodontal disease mainly affects the surface of the teeth or roots, and the gums face this biofilm and cause symptoms such as swelling.

歯ぐきの腫れを抑えるような薬は症状を和らげるための治療法でしかなく、原因を取り除くための根本治療にはならない。抗生物質(化膿止め)を用いても、バイオフィルム内には薬が浸透しずらいため、単独の細菌に用いるよりも100〜500倍高い濃度を必要とする。これでは生体のほうに強い副作用が出てしまうことになる。現在、市販の歯磨き剤や歯科治療で用いられているものでは劇物を含むものが多く、たとえ歯周病菌を殺菌できたとしても、生体への影響を無視するものであった。また、カテキンなど漢方による薬剤では、口腔内の除菌効果は期待できるもののバイオフィルム内へ浸透することができないので、バイオフィルム内の歯周病菌を完全に殺菌するまでにはいたらない。Drugs that reduce gum swelling are only treatments to relieve symptoms and not a fundamental treatment to remove the cause. Even if an antibiotic (suppuration) is used, it is difficult for the drug to penetrate into the biofilm, so a concentration 100 to 500 times higher than that used for a single bacterium is required. This will cause stronger side effects on the body. At present, many commercially available dentifrices and those used in dental treatment include deleterious substances, and even if periodontal disease bacteria can be sterilized, the influence on the living body is ignored. Moreover, although medicines by Chinese medicine such as catechin can be expected to eliminate bacteria in the oral cavity but cannot penetrate into the biofilm, it is not necessary to completely sterilize the periodontal disease bacteria in the biofilm.

また、歯科医院においてデンタルプラークを除去してもらっても、一時しのぎであり、歯磨きが充分にできない者にとっては、再度デンタルプラークが形成される。これらの理由が、歯周病予防と治療が困難になっている大きな要因になっている。Moreover, even if the dental plaque is removed at the dental clinic, it is only temporary and a dental plaque is formed again for those who cannot fully brush their teeth. These reasons are the major factors that make it difficult to prevent and treat periodontal disease.

そこで、個人でも容易に用いることができ、バイオフィルム内の歯周病菌を殺菌できる、且つ生体にも安全な歯周病予防或いは歯周病の治療薬剤の開発が望まれていた。Therefore, it has been desired to develop a therapeutic agent for periodontal disease prevention or periodontal disease that can be easily used by individuals, can sterilize periodontal bacteria in a biofilm, and is safe for the living body.

特許第3284042号 歯周病の予防用或いは治療用組成物Patent No. 3284402 Composition for preventing or treating periodontal disease 特表2003−519167微生物による接着を阻害するための方法及び組成物JP 2003-519167 A Method and Composition for Inhibiting Adhesion by Microorganisms 特表2004−511506口腔内のバクテリアによるプラークおよび/またはバクテリアを除去または低減するための口内衛生製品の調製におけるオリーブオイルの用途Use of olive oil in the preparation of oral hygiene products to remove or reduce plaque and / or bacteria caused by bacteria in the oral cavity 特表2005−533864ラクトフェリンを含む組成物Composition containing JP 2005-533864 lactoferrin 特開2000−256155口腔用組成物JP-A 2000-256155 Oral composition 特公平7−25670抗歯周病剤Japanese Patent Publication No. 7-25670 anti-periodontal disease agent 特公平8−13738歯垢除去剤及び歯石沈着防止剤Japanese Patent Publication No. 8-13738 plaque remover and calculus deposition inhibitor WO2003/094878ガロカテキンガレート含有組成物WO2003 / 094878 gallocatechin gallate-containing composition 特開平5−944歯周病原因菌付着阻害用組成物Composition for inhibiting adhesion of periodontal disease-causing bacteria 特開平6−56687歯垢除去剤及び歯石沈着防止剤JP-A-6-56687 plaque remover and calculus deposition inhibitor 特開2004−315414歯石形成抑制剤JP 2004-315414 calculus formation inhibitor Azakami H.et al.2006.Biosci.Biotechnol.Biochem.70:441−446.Azakami H. et al. et al. 2006. Biosci. Biotechnol. Biochem. 70: 441-446. Rezai−Zadeh K.et al.2005.J.Neurosci.25(38):8807−14.Rezai-Zadeh K.M. et al. 2005. J. et al. Neurosci. 25 (38): 8807-14. Yamada M.et al.2002.J.Med.Microbiol.51(12):1080−89.Yamada M. et al. et al. 2002. J. et al. Med. Microbiol. 51 (12): 1080-89. Djordjevic D.et al.2002.Appl.Environ.Microbiol.68:2950−58.Djordjevic D.D. et al. 2002. Appl. Environ. Microbiol. 68: 2950-58. DENTAL TODAY 学術フォーム2000.4.1号:No.1各種水酸化カルシウム剤の浸透性を比較DENTAL TODAY Academic Form 2000.4.1: No. 1Comparing the permeability of various calcium hydroxide agents

上記の現状に鑑み、本発明者は、ヒトの口腔内で、より有効に歯周病を抑制する薬剤の開発を複数の歯周病菌が、バイオフィルム形成の初期段階に関与し、その後バイオフィルムによって保護された状態下に、Streptococcus mutansやPorphyromonas gingivalisなどの主要歯周病菌が繁殖し、強固な歯垢や歯石を形成すると推測した。In view of the above situation, the present inventor has developed a drug that more effectively suppresses periodontal disease in the human oral cavity, a plurality of periodontal pathogens are involved in the initial stage of biofilm formation, and then biofilm It was speculated that major periodontal bacteria such as Streptococcus mutans and Porphyromonas gingivalis propagated under the condition protected by, and formed strong plaque and tartar.

そこで、本発明者らは、まずバイオフィルムを破壊する薬剤を検討した。Therefore, the present inventors first examined a drug that destroys a biofilm.

その結果、驚くべきことに、ホタテ貝などの貝殻焼成カルシウムによる水溶液が口腔中でのバイオフィルムの細胞を破壊する効果を有することを見出し、本発明を完成するに至った。As a result, it has been surprisingly found that an aqueous solution of calcined shell calcium such as scallop has an effect of destroying biofilm cells in the oral cavity, and the present invention has been completed.

そこで本発明は、次の態様からなる。
(1)本発明の第1の態様は、貝殻焼成カルシウムを有効成分とするバイオフィルムの破壊と活性阻害剤である。
(2)本発明の第2の態様は、前記第1の態様に記載のバイオフィルムの破壊と活性阻害剤を有効成分とする口腔内でのバイオフィルム生成抑制剤である。
(3)本発明の第3の態様は、上記第2の態様に記載のバイオフィルム生成抑制剤を有効成分とする歯科用薬剤である。
(4)本発明の第4の態様は、上記第1の態様又は第2の態様に記載のバイオフィルムの活性阻害剤を有効成分とする歯周病治療及び予防用薬剤である。
Therefore, the present invention comprises the following aspects.
(1) The first aspect of the present invention is a biofilm destruction and activity inhibitor containing calcined shell calcium as an active ingredient.
(2) The second aspect of the present invention is a biofilm production inhibitor in the oral cavity containing the biofilm destruction and activity inhibitor as described in the first aspect as active ingredients.
(3) A third aspect of the present invention is a dental agent containing the biofilm formation inhibitor according to the second aspect as an active ingredient.
(4) A fourth aspect of the present invention is a therapeutic and preventive agent for periodontal disease comprising the biofilm activity inhibitor described in the first aspect or the second aspect as an active ingredient.

本発明を利用することにより、複数の歯周病細菌の集合体であるバイオフィルムを破壊し効果的に殺菌することが可能となり、延いてはその他の歯周病細菌の増殖を容易に抑制することができ、歯周病や口臭の原因となるデンタルプラークの予防となる。By utilizing the present invention, it becomes possible to destroy and effectively sterilize a biofilm that is an aggregate of a plurality of periodontal disease bacteria, and thus easily suppress the growth of other periodontal disease bacteria. Can prevent dental plaque causing periodontal disease and bad breath.

本発明の最大のポイントは、デンタルプラークの活性を阻害するため、貝殻焼成カルシウムが特異的に効果を有すること、具体的には、口腔内でのバイオフィルム細胞を破壊し、殺菌することで、その形成を抑制することを見出した点にある。The greatest point of the present invention is to inhibit the activity of dental plaque, so that shell calcined calcium has a specific effect, specifically, by destroying and sterilizing biofilm cells in the oral cavity, It exists in the point which discovered that the formation was suppressed.

貝殻焼成カルシウムは、食品添加物として一般に用いられているなど、生体への安全性についてはよく知られている。Shell-calcined calcium is well known for safety to living bodies, such as being commonly used as a food additive.

水酸化カルシウム剤は,歯内療法において広く用いられるようになってきており,アペキシフィケーションなどの用途では,根尖周囲組織への浸透性が治療効果に関わるともみられることから,注目されている。Calcium hydroxide has been widely used in endodontic therapy, and in applications such as apexification, it has been attracting attention because permeation into the periapical tissue may be related to the therapeutic effect. Yes.

貝殻焼成カルシウムは、0.1%水溶液にすることでPH12以上の高アルカリ性溶液となり、大腸菌をはじめサルモネラや白癬菌など多くの細菌に対しての殺菌効果があることも知られている。It is also known that calcined shell calcium is a highly alkaline solution with a pH of 12 or more when made into a 0.1% aqueous solution and has a bactericidal effect against many bacteria such as Escherichia coli, Salmonella and ringworm.

また、貝殻焼成カルシウムを0.1〜0.2%水溶液にすることにすることにより、PH12以上の高アルカリ性となり、主にたんぱく質から組成されているバイオフィルムを破壊する。Moreover, by making the shell calcined calcium into a 0.1 to 0.2% aqueous solution, it becomes highly alkaline with a pH of 12 or more, and the biofilm mainly composed of protein is destroyed.

しかし、このような効果があるにも関らず、貝殻焼成カルシウムを歯周病予防及び歯周病治療に用いられることはほとんどなかったのである。
そのため、貝殻焼成カルシウムの持つ特異的な作用効果は全く知られていなかった。
However, despite these effects, the calcined shell calcium was rarely used for periodontal disease prevention and periodontal disease treatment.
Therefore, the specific action and effect of the calcined shell calcium has not been known at all.

本発明の特徴は、貝殻焼成カルシウムを有効成分として、バイオフィルムを破壊し歯周病菌を殺菌するものである。The feature of the present invention is to destroy biofilms and kill periodontal bacteria by using calcined calcium shell as an active ingredient.

以下に本発明の実施例を示すが、本発明は実施例に限定されるものではない。Examples of the present invention are shown below, but the present invention is not limited to the examples.

コップにホタテなどの貝殻焼成カルシウムを0.1〜0.2%含む水溶液をつくる。An aqueous solution containing 0.1 to 0.2% of calcined calcium such as scallops in a glass is prepared.

以上の要領で作ったカルシウム水溶液を口に含み、約1分うがいをする。Gently gargle for about 1 minute with the calcium aqueous solution made in the above manner in the mouth.

歯ブラシをコップ内のカルシウム水溶液に浸しながら、歯と歯ぐきの境界を重点的に歯磨きを行なう。この時の歯磨き時間は、3分以上が望ましい。While soaking the toothbrush in the aqueous calcium solution in the cup, brush the teeth with a focus on the boundary between the teeth and the gums. The tooth brushing time at this time is preferably 3 minutes or more.

歯磨き中もコップ内のカルシウム水溶液によるうがいを行なう。Gargle with the aqueous calcium solution in the cup while brushing your teeth.

歯ブラシによる歯磨きが終了後、歯間ブラシを用いて歯間を磨く。After finishing brushing with a toothbrush, use an interdental brush to brush between the teeth.

最後に、歯ブラシを用い、口臭の最大原因である舌を丁寧に傷つけないようにして磨く。Finally, use a toothbrush to polish the tongue, which is the biggest cause of bad breath, without damaging the tongue.

コップに水道水を入れ、複数回うがいをして口腔内のカルシウム水溶液を洗い流し、口腔内のPHを中性に戻す。Tap water into the cup, gargle multiple times to wash away the aqueous calcium solution in the oral cavity, and return the oral pH to neutral.

本発明の提供するバイオフィルム抑制剤は、バイオフィルムを効果的に破壊し抑制可能にするものであり、歯周病予防や口臭治療の重要性が認識されている今日において、口腔衛生産業等に利用する事が可能である。The biofilm inhibitor provided by the present invention is capable of effectively destroying and suppressing biofilms, and today, the importance of preventing periodontal disease and treating bad breath is recognized in the oral hygiene industry and the like. It is possible to use.

さらに、本発明の提供するバイオフィルム抑制剤を歯科医療の分野に利用することで、より効果的に歯周病の原因であるバイオフィルムを破壊でき、多くの口臭や歯周病に悩む患者を救うことが可能になる。Furthermore, by using the biofilm inhibitor provided by the present invention in the field of dentistry, biofilms that cause periodontal diseases can be more effectively destroyed, and patients suffering from many bad breath and periodontal diseases It becomes possible to save.

Claims (3)

貝殻焼成カルシウムを0.1〜0.2%水溶液にすることで得られるPH12以上の高アルカリ性溶液を含有する組成物であって、バイオフィルムを破壊する口腔用組成物。A composition for oral cavity that destroys a biofilm, comprising a highly alkaline solution having a pH of 12 or more obtained by making calcined shell calcium into a 0.1 to 0.2% aqueous solution. 貝殻焼成カルシウムを0.1〜0.2%水溶液にすることで得られるPH12以上の高アルカリ性溶液を含有する組成物であって、バイオフィルム生成を抑制する口腔用組成物。An oral cavity composition containing a highly alkaline solution having a pH of 12 or more obtained by making calcined shell calcium into an aqueous solution of 0.1 to 0.2% and suppressing biofilm formation. 貝殻焼成カルシウムを0.1〜0.2%水溶液にすることで得られるPH12以上の高アルカリ性溶液を含有する組成物であって、口腔内細菌を殺菌または除菌する口腔用組成物。An oral composition comprising a highly alkaline solution having a pH of 12 or more obtained by making calcined shell calcium into a 0.1 to 0.2% aqueous solution, wherein the oral bacteria are sterilized or sterilized.
JP2009241844A 2009-09-28 2009-09-28 Composition used for preventing and treating periodontal disease Pending JP2011068630A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009241844A JP2011068630A (en) 2009-09-28 2009-09-28 Composition used for preventing and treating periodontal disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009241844A JP2011068630A (en) 2009-09-28 2009-09-28 Composition used for preventing and treating periodontal disease

Publications (1)

Publication Number Publication Date
JP2011068630A true JP2011068630A (en) 2011-04-07

Family

ID=44014272

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009241844A Pending JP2011068630A (en) 2009-09-28 2009-09-28 Composition used for preventing and treating periodontal disease

Country Status (1)

Country Link
JP (1) JP2011068630A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014024825A (en) * 2012-07-24 2014-02-06 Mitsuhiro Tomishige Body-care agent
JP2016132665A (en) * 2015-01-15 2016-07-25 寅之介 窪田 Light emitting aqueous nail top coat
KR102072442B1 (en) * 2019-02-27 2020-02-03 임이종 Mouthwash comprising mineral calcium and process for producing the same

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014024825A (en) * 2012-07-24 2014-02-06 Mitsuhiro Tomishige Body-care agent
JP2016132665A (en) * 2015-01-15 2016-07-25 寅之介 窪田 Light emitting aqueous nail top coat
KR102072442B1 (en) * 2019-02-27 2020-02-03 임이종 Mouthwash comprising mineral calcium and process for producing the same

Similar Documents

Publication Publication Date Title
JP6295274B2 (en) Treatment of periodontal disease
Basrani et al. Update on endodontic irrigating solutions
US20220088001A1 (en) Method and System for Reducing the Likelihood of a Porphyromonas Gingivalis Infection in a Human Being
Quirynen et al. Review of the treatment strategies for oral malodour
US20080057007A1 (en) Oral hygiene products containing ascorbic acid and method of using the same
AU2014248562B2 (en) Oral formulation of polyglucosamine derivatives in combination with a non-fermentable sugar
AU2006332076B2 (en) Cleansing composition
EP2459149A2 (en) Antibacterial combinations comprising a garlic extrtact or s-allyl cysteine
Leventis et al. Topical oxygen therapy as a novel strategy to promote wound healing and control the bacteria in implantology, oral surgery and periodontology: A review
Jain et al. Papacarie: a chemomechanical caries removal agent
JP2011068630A (en) Composition used for preventing and treating periodontal disease
Kaur et al. Evaluation and comparison of short term side effects of 0.2% and 0.12% chlorhexidine mouthwash
CA3114810A1 (en) Silicic acids for use in the treatment of periodontitis
Jyoti et al. Ozone in dental therapy: an outlook
US20080299051A1 (en) Pharmaceutical composition for the oral hygiene, the treatment of the periodontal illnesses and the halitosis
Kashyap et al. Irrigating solutions in pediatric dentistry: a big deal in little teeth
JP2019127475A (en) Oral disinfectants
Manonmanipavithra et al. A review on chlorhexidine in periodontal therapy
JP2011111455A (en) Dentifrice applied for prevention and treatment of periodontal disease
Kaur et al. Dental Caries: A Review on Etiology, Therapeutic Approaches, Novel Formulations, and Marketed Preparations
Basrani et al. Topical disinfectants for root canal irrigation
RU2545764C1 (en) Method of treating periodontitis
Kannan et al. Effectiveness of chlorhexidine on patients with periodontitis.
Verma et al. Various applications of chlorhexidine as an antimicrobial agent in dentistry: A review.
Alghamdi et al. Topical Oxygen Therapy: A novel Strategy for Oral Healthcare